Akki what do you have to say about the valuation?
All I've heard from your last 30 posts or so is that the company needs cash but what thoughts do you have about the scientific, clinical, regulatory and commercial aspects of the company?
- Forums
- ASX - By Stock
- PER
- Biopharma Notes
Biopharma Notes, page-11
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.9¢ | $16.86K | 210.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 122542 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 65906 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 122542 | 0.079 |
2 | 28159 | 0.078 |
1 | 10000 | 0.077 |
1 | 26000 | 0.076 |
4 | 196800 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 65906 | 3 |
0.081 | 100000 | 1 |
0.083 | 100000 | 1 |
0.084 | 100250 | 1 |
0.085 | 220000 | 2 |
Last trade - 15.05pm 22/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online